HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pre-discharge iron status and its determinants in premature infants.

AbstractOBJECTIVE:
To evaluate pre-discharge iron status and identify its determinants in infants' ≤ 32 weeks gestational age (GA).
METHODS:
In a prospective observational study, 24-32 weeks GA infants who did not meet exclusion criteria: congenital viral infections, chromosomal disorders, or cranio-facial anomalies were eligible. Iron status was evaluated by measuring serum ferritin (SF) at 35 weeks post-menstrual age (PMA). Infants with infection or elevated C-reactive protein within 10 days prior to evaluation of iron status were excluded.
RESULTS:
Of 131 infants studied, 23% had latent iron deficiency (SF < 76 ng/ml), 58% had normal iron status (75-400 ng/ml), and 19% had iron overload (SF > 400 ng/ml). On bivariate analysis, preeclampsia, GA, birth weight, patent ductus arteriosus, prior erythrocyte transfusion, phlebotomy loss, and chronic lung disease were associated with iron status. On ordered logistic regression, prior erythrocyte transfusion (frequency [OR 1.41, 95% CI:1.2-1.6] or cumulative amount [OR 1.03, 95% CI:1.02-1.04]) or net erythrocyte balance (amount of erythrocyte transfusion minus phlebotomy loss; OR 1.04, 95% CI:1.02-1.05) was significantly associated with iron status. Among infants who received > three erythrocyte transfusions, 50% developed iron overload.
CONCLUSIONS:
Iron status at 35 weeks PMA is extremely variable and is predicted by prior erythrocyte transfusions or net erythrocyte balance in premature infants.
AuthorsSanjiv B Amin, Lori Scholer, Manisha Srivastava
JournalThe journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (J Matern Fetal Neonatal Med) Vol. 25 Issue 11 Pg. 2265-9 (Nov 2012) ISSN: 1476-4954 [Electronic] England
PMID22734563 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Iron
Topics
  • Ductus Arteriosus, Patent (blood, epidemiology, therapy)
  • Female
  • Gestational Age
  • Health Status
  • Humans
  • Infant, Newborn
  • Infant, Premature (blood)
  • Infant, Premature, Diseases (blood, epidemiology, therapy)
  • Intensive Care Units, Neonatal (statistics & numerical data)
  • Iron (blood)
  • Iron Overload (blood, epidemiology, etiology)
  • Male
  • Patient Discharge (statistics & numerical data)
  • Pregnancy
  • Transfusion Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: